{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T03:14:45Z","timestamp":1788059685352,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tvjl.2026.106787","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:07:10Z","timestamp":1785341230000},"page":"106787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-tumour activity of canine activated T-cells and cytokine-induced killer cells against canine malignant melanoma in vitro"],"prefix":"10.1016","volume":"319","author":[{"given":"Luiza Cesar","family":"Conti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Capellero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7773-893X","authenticated-orcid":false,"given":"Sabina","family":"Iurascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Erriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marconato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"De Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106787_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2015.11.003","article-title":"Cancer immunology and canine malignant melanoma: A comparative review","volume":"169","author":"Atherton","year":"2016","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2026.106787_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1158\/1538-7445.AM2022-1363","article-title":"Abstract 1363: Preclinical development of bispecific CAR-T cells for canine B cell malignancies","volume":"82","author":"Atherton","year":"2022","journal-title":"Cancer Research"},{"key":"10.1016\/j.tvjl.2026.106787_bib3","first-page":"1","article-title":"Adoptive cell transfer: new perspective treatment in veterinary oncology","author":"Bujak","year":"2018","journal-title":"Acta Veterinaria Scandinavica"},{"key":"10.1016\/j.tvjl.2026.106787_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00262-024-03642-4","article-title":"Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity","volume":"73","author":"Cao","year":"2024","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/j.tvjl.2026.106787_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2017.06.003","article-title":"Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells","volume":"36","author":"Cappuzzello","year":"2017","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.tvjl.2026.106787_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1229540","article-title":"How can cytokine-induced killer cells overcome CAR-T cell limits","volume":"14","author":"Cappuzzello","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.tvjl.2026.106787_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00262-025-04163-4","article-title":"Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation","volume":"74","author":"De Maria","year":"2025","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/j.tvjl.2026.106787_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670309","article-title":"Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target","volume":"12","author":"Gingrich","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.tvjl.2026.106787_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40880-015-0002-1","article-title":"Cytokine-induced killer (CIK) cells: From basic research to clinical translation","volume":"34","author":"Guo","year":"2015","journal-title":"Chinese Journal of Cancer"},{"key":"10.1016\/j.tvjl.2026.106787_bib10","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.3390\/ijms251910387","article-title":"The Comparative Oncology of Canine Malignant Melanoma in Targeted Therapy: A Systematic Review of In Vitro Experiments and Animal Model Reports","volume":"25","author":"He","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.tvjl.2026.106787_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13102302","article-title":"Recruitment, infiltration and cytotoxicity of hla-independent killer lymphocytes in three-dimensional melanoma models","volume":"13","author":"Iaia","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tvjl.2026.106787_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1292\/jvms.66.1437","article-title":"Establishment and Characterization of Four Canine Melanoma Cell Lines","volume":"66","author":"Inoue","year":"2004","journal-title":"Journal of Veterinary Medical Science"},{"key":"10.1016\/j.tvjl.2026.106787_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020358","article-title":"Innovative clinical perspectives for cik cells in cancer patients","volume":"19","author":"Introna","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.tvjl.2026.106787_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4110\/in.2015.15.2.58","article-title":"Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Network"},{"key":"10.1016\/j.tvjl.2026.106787_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","author":"Laskowski","year":"2022","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.tvjl.2026.106787_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-020-0297-3","article-title":"Improving human cancer therapy through the evaluation of pet dogs","volume":"20","author":"LeBlanc","year":"2020","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.tvjl.2026.106787_bib17","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/1078-0432.CCR-20-0357","article-title":"CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes","volume":"26","author":"Leuci","year":"2020","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.tvjl.2026.106787_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/CJI.0000000000000052","article-title":"Toward Immunotherapy With Redirected T Cells in a Large Animal Model","volume":"37","author":"Mata","year":"2014","journal-title":"Journal of Immunotherapy"},{"key":"10.1016\/j.tvjl.2026.106787_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/21645515.2017.1285987","article-title":"Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application","volume":"13","author":"Meng","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.tvjl.2026.106787_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2013.06.013","article-title":"Isolation and characterization of canine natural killer cells","volume":"155","author":"Michael","year":"2013","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2026.106787_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diseases10030060","article-title":"Emerging Trends in Immunotherapy for Cancer","volume":"10","author":"Mishra","year":"2022","journal-title":"Diseases"},{"key":"10.1016\/j.tvjl.2026.106787_bib22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","article-title":"Comparative oncology: overcoming human cancer through companion animal studies","volume":"55","author":"Oh","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.tvjl.2026.106787_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1292\/jvms.63.83","article-title":"Effect of Retinoids on Growth Inhibition of Two Canine Melanoma Cell Lines","volume":"63","author":"Ohashi","year":"2001","journal-title":"Journal of Veterinary Medical Science"},{"key":"10.1016\/j.tvjl.2026.106787_bib24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2016.146","article-title":"Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma","volume":"24","author":"Panjwani","year":"2016","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.tvjl.2026.106787_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40425-016-0200-7","article-title":"Canine cancer immunotherapy studies: linking mouse and human","volume":"4","author":"Park","year":"2016","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.tvjl.2026.106787_bib26","article-title":"Melanoma of the dog and cat: consensus and guidelines","volume":"11","author":"Polton","year":"2024","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106787_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/mco.2022.2567","article-title":"Advances and challenges of CAR T therapy and suitability of animal models (Review)","volume":"17","author":"Ramos\u2011Cardona","year":"2022","journal-title":"Molecular and Clinical Oncology"},{"key":"10.1016\/j.tvjl.2026.106787_bib28","article-title":"Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer","volume":"12","author":"Razmara","year":"2024","journal-title":"Journal for Immuno Therapy of Cancer"},{"key":"10.1016\/j.tvjl.2026.106787_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1336158","article-title":"Improved characterization and translation of NK cells for canine immunotherapy","author":"Razmara","year":"2024","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106787_bib30","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-13-3042","article-title":"CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA","volume":"20","author":"Riccardo","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.tvjl.2026.106787_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100905","article-title":"Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer","volume":"2","author":"Rotolo","year":"2021","journal-title":"STAR Protocols"},{"key":"10.1016\/j.tvjl.2026.106787_bib32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.21873\/invivo.12763","article-title":"Optimization of Culture Conditions for the Generation of Canine CD20-CAR-T Cells for Adoptive Immunotherapy","volume":"36","author":"Sakai","year":"2022","journal-title":"In Vivo"},{"key":"10.1016\/j.tvjl.2026.106787_bib33","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28269","article-title":"Activity of cytokine-induced killer cells against bone and soft tissue sarcoma","volume":"3","author":"Sangiolo","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.tvjl.2026.106787_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-021-02184-2","article-title":"30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective","volume":"40","author":"Sharma","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.tvjl.2026.106787_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigment Cell & Melanoma Research"},{"key":"10.1016\/j.tvjl.2026.106787_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1046636","article-title":"Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies","author":"Stevenson","year":"2023","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106787_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41587-025-02629-5","article-title":"Engineering innate immune cells for cancer immunotherapy","volume":"43","author":"Tarannum","year":"2025","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.tvjl.2026.106787_bib38","article-title":"Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma","volume":"10","author":"Wang","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.tvjl.2026.106787_bib39","first-page":"1","article-title":"NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation","volume":"12","author":"Wu","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.tvjl.2026.106787_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vetsci11040150","article-title":"Limited Clinical Efficacy with Potential Adverse Events in a Pilot Study of Autologous Adoptive Cell Therapy in Canine Oral Malignant Melanoma","volume":"11","author":"Xia","year":"2024","journal-title":"Veterinary Sciences"},{"key":"10.1016\/j.tvjl.2026.106787_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/1535-7163.MCT-21-0726","article-title":"B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model","volume":"21","author":"Zhang","year":"2022","journal-title":"Molecular Cancer Therapeutics"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:17:47Z","timestamp":1788056267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326002431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S1090023326002431"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106787","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumour activity of canine activated T-cells and cytokine-induced killer cells against canine malignant melanoma in vitro","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106787"}}